Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Moderna (MRNA)
NASDAQ:MRNA
Moderna (MRNA) Stock Price & Analysis
14,268 Followers
MRNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$62.55 - $217.25
Previous Close$78.28
Volume4.40M
Average Volume (3M)4.08M
Market Cap
$30.45B
Enterprise Value$24.15B
Total Cash (Recent Filing)$7.57B
Total Debt (Recent Filing)$1.27B
Price to Earnings (P/E)-8.4
Beta1.31
Next Earnings
Feb 22, 2024EPS Estimate
-$1.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.34
Shares Outstanding381,283,996
10 Day Avg. Volume2,741,356
30 Day Avg. Volume4,079,376
Standard Deviation0.26
R-Squared0.11
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.27
Price to Sales (P/S)1.55
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.98
Enterprise Value/Gross Profit1.74
Enterprise Value/Ebitda-6.72
Forecast
1Y Price Target
$118.27Price Target Upside46.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Moderna News
Market NewsQQQ ETF Update, 12/6/2023
Market NewsSPY ETF Update, 12/4/2023
Market NewsSPY ETF Update, 11/30/2023
Market NewsQQQ ETF Update, 11/30/2023
Ownership Overview
0.00% Insiders
17.00% Mutual Funds
43.13% Other Institutional Investors
39.87% Public Companies and Individual Investors
MRNA FAQ
What was Moderna’s price range in the past 12 months?
Moderna lowest stock price was $62.55 and its highest was $217.25 in the past 12 months.
What is Moderna’s market cap?
Currently, no data Available
When is Moderna’s upcoming earnings report date?
Moderna’s upcoming earnings report date is Feb 22, 2024 which is in 77 days.
How were Moderna’s earnings last quarter?
Moderna released its earnings results on Nov 02, 2023. The company reported -$9.53 earnings per share for the quarter, missing the consensus estimate of -$1.932 by -$7.598.
Is Moderna overvalued?
According to Wall Street analysts Moderna’s price is currently Undervalued.
Does Moderna pay dividends?
Moderna does not currently pay dividends.
What is Moderna’s EPS estimate?
Moderna’s EPS estimate is -$1.4.
How many shares outstanding does Moderna have?
Moderna has 381,284,000 shares outstanding.
What happened to Moderna’s price movement after its last earnings report?
Moderna reported an EPS of -$9.53 in its last earnings report, missing expectations of -$1.932. Following the earnings report the stock price went down -6.522%.
Which hedge fund is a major shareholder of Moderna?
Among the largest hedge funds holding Moderna’s share is Flagship Pioneering Inc.. It holds Moderna’s shares valued at 998M.
---
Moderna Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$118.27 (46.74% Upside)
$118.27 (46.74% Upside)
Blogger Sentiment
Bullish
MRNA Sentiment 61%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 5.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.50%
12-Months-Change
Fundamentals
Return on Equity
-22.04%
Trailing 12-Months
Asset Growth
-25.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Moderna
Incorporated in 2010, Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on messenger ribonucleic acid (mRNA) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
---
Top 5 ETFs holding MRNA
Global X S&P 500 Covered Call ETF
$2.06M
iShares ESG Screened S&P 500 ETF
$130.34K
Global X S&P 500 Covered Call & Growth ETF
$44.25K
Global X S&P 500 ESG Covered Call ETF
$2.00K
Global X S&P 500 Tail Risk ETF
$2.00K
Up to five ETFs with an Outperform Smart Score that hold MRNA. The ETFs are listed according to market value of MRNA within the ETF
---